Regeneron Pharmaceuticals
REGN
#243
Rank
โ‚น9.269 T
Marketcap
โ‚น89,609
Share price
-0.86%
Change (1 day)
48.37%
Change (1 year)

Regeneron Pharmaceuticals (REGN) Fails to deliver data

Key failure to deliver metrics for Regeneron Pharmaceuticals:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Regeneron Pharmaceuticals (REGN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Regeneron Pharmaceuticals (REGN) - since 2013

Volume in USD (price x number of shares), data since 2013

Regeneron Pharmaceuticals (REGN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024โ‚น65.44 M-45.21%
2023โ‚น0.11 B-5.6%
2022โ‚น0.12 B-53.05%
2021โ‚น0.26 B5.23%
2020โ‚น0.25 B414.86%
2019โ‚น49.73 M-31.98%
2018โ‚น73.11 M69.52%
2017โ‚น43.12 M-78.72%
2016โ‚น0.20 B3.03%
2015โ‚น0.19 B-15.29%
2014โ‚น0.23 B419.89%
2013โ‚น44.67 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Johnson & Johnson
JNJ
โ‚น0.18 Bโ‚น0.40 B๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น32.89 Mโ‚น0.43 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚น25.92 Mโ‚น0.45 B๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น19.95 Mโ‚น38.55 M๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
โ‚น20.61 Mโ‚น31.81 M๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น5.86 Mโ‚น39.58 M๐Ÿ‡บ๐Ÿ‡ธ USA